ROQAF (Roquefort Therapeutics) Effective Interest Rate on Debt % : 12.17% (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Roquefort Therapeutics Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Roquefort Therapeutics's annualized positive value of Interest Expense for the quarter that ended in Dec. 2024 was $0.08 Mil. Roquefort Therapeutics's average total debt for the quarter that ended in Dec. 2024 was $0.64 Mil. Therefore, Roquefort Therapeutics's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2024 was 12.17%.

Roquefort Therapeutics Effective Interest Rate on Debt % Historical Data

The historical data trend for Roquefort Therapeutics's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roquefort Therapeutics Effective Interest Rate on Debt % Chart

Roquefort Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Effective Interest Rate on Debt %

11.26

Roquefort Therapeutics Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Effective Interest Rate on Debt %	Get a 7-Day Free Trial			-	-	-	4.64	12.17

Competitive Comparison of Roquefort Therapeutics's Effective Interest Rate on Debt %

For the Biotechnology subindustry, Roquefort Therapeutics's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Roquefort Therapeutics's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Roquefort Therapeutics's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Roquefort Therapeutics's Effective Interest Rate on Debt % falls into.

Save Embed

;

Save Embed

;

Roquefort Therapeutics Effective Interest Rate on Debt % Calculation

Roquefort Therapeutics's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2024 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (A: Dec. 2023 )	+	Total Debt (A: Dec. 2024 ))	/ count )
=	-1 * -0.057	/	( (0	+	0.506)	/ 1 )
=	-1 * -0.057	/	0.506
=	11.26 %

where

	Total Debt (A: Dec. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0	+	0
=	0

	Total Debt (A: Dec. 2024 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0	+	0.506
=	0.506

Roquefort Therapeutics's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2024 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (Q: Jun. 2024 )	+	Total Debt (Q: Dec. 2024 ))	/ count )
=	-1 * -0.078	/	( (0.776	+	0.506)	/ 2 )
=	-1 * -0.078	/	0.641
=	12.17 %

where

	Total Debt (Q: Jun. 2024 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0	+	0.776
=	0.776

	Total Debt (Q: Dec. 2024 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0	+	0.506
=	0.506

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is two times the semi-annual (Dec. 2024) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

Roquefort Therapeutics (OTCPK:ROQAF) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Roquefort Therapeutics Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Roquefort Therapeutics's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

Roquefort Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Roquefort Therapeutics PLC (OTCPK:ROQAF) » Definitions » Effective Interest Rate on Debt %

Comparable Companies

Traded in Other Exchanges

ROQ:UK

Address

85 Great Portland Street, First Floor, London, GBR, W1W 7LT

Website

https://www.roquefortplc.com

Roquefort Therapeutics PLC is engaged in pursuing opportunities to acquire medical biotechnology businesses. Its product portfolio consists of MDK Antibody, MDK Oligo, MDK mRNA, STAT-6 siRNA, and MK Cell. The principal activity of the Company is to develop pre-clinical next-generation medicines focused on hard-to-treat cancers.

Roquefort Therapeutics Headlines

From GuruFocus

Roquefort Therapeutics PLC at OTC Markets Life Science Investor Forum (Virtual) Transcript

By GuruFocus Research • 03-27-2024